In recent months, there has been laser focus on the regulatory process surrounding CBD, and the U.S. Food and Drug Administration (FDA) is working on speeding up this process, as it is the agency’s goal to ensure consumers are purchasing only the safest products. The FDA also wants companies to be held accountable for what they produce. One of the ultimate hopes, however, is for “more businesses [to be] able to participate in the industry, increasing economic gain, competition and product variety.” This is great news for your company. Let’s learn why.
Proceed With Caution
While consumers and businesses were both skeptical about the FDA’s decision to get involved because of the stigma attached to alternative medicine, the FDA has in fact recognized the medicinal benefits of CBD products. It is impossible to drown out the public’s interest and demand for what CBD has to offer.
The FDA’s regulation will mandate company honesty, including the source of their CBD and accurate listings of the filler included in their products. Guidelines will summon information necessary for the FDA to deem CBD product efficacy, safety, and quality. You see, that’s the reassuring thing about Stock CBD Supplements. Our CBD goes through rigorous third-party lab testing and is manufactured in an FDA and GMP registered facility. We ALREADY adhere to the strictest guidelines and comply with regulatory requirements pertaining to the CBD manufacturing industry, so YOU don’t have to sweat whether what you are providing customers is compliant.
Isn’t CBD just a fad? Well, despite the chatter about CBD being a phase, it IS helping thousands of people live their best lives. From anxiety reduction to pain relief, the compound’s endless benefits attribute to not only the speed at which consumers are buying CBD products, but its surging growth. CBD is predicted to grow 700% by 2020, proving itself to be one of the most lucrative markets for investors and brands to jump into. In fact, the U.S. market alone is projected to hit ~ $20 billion by 2024. This is the perfect time for your white label CBD line to soar.
Why Regulation Matters
Currently, as long as it adheres to authorized guidelines, hemp-derived CBD is protected under the 2018 Farm Bill. This legislation paved the way for companies to source their CBD and introduce a range of products to the market. CBD sourced from overseas, however, may be susceptible to toxins in the soil that would not be allowed with domestic growing projects—which is just one reason why the FDA must be able to monitor CBD companies. Did I mention we source our CBD from within the U.S. only?
Another reason why regulation matters: accuracy. The FDA will be surveilling claims being made, which means companies will be checked. Say your competition touts CBD as a cure-all… there is a big chance they will be in violation with compliance and will not be able to sell their product, which brings me to another key reason to choose Stock CBD Supplements. Our compliance team ensures that your private label CBD supplement label does not display any outstanding claims, that they are all in compliance with established regulations.
Similar to the FDA, our high standards are of paramount importance. We want your brand to beat the others on the market, which, might I add, is exploding with competition. Our expertise and quality of service will put you ahead of the curve and give you the peace of mind that your business is in safe hands. Request a quote today!